{"id":"W4248307030","doi":"10.1200/jco.2011.29.7_suppl.160","title":"Phase II study of maintenance therapy with temsirolimus (TEM) after response to first-line docetaxel (TAX) chemotherapy in castration-resistant prostate cancer (CRPC).","year":2011,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; London Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Clinical endpoint; Temsirolimus; Docetaxel; Prostate cancer; Internal medicine; Oncology; Everolimus; Chemotherapy; Urology; Cancer; PI3K/AKT/mTOR pathway; Clinical trial; Discovery and development of mTOR inhibitors","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002477967,0.001776748,0.002664167,0.0006745385,0.0005811498,0.001419114,0.001706864,0.002221814,0.003688153],"category_scores_gemma":[0.001388888,0.0008618466,0.001227696,0.0005728705,0.001465369,0.001310019,0.0004458157,0.004544856,0.00127467],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001104403,"about_ca_system_score_gemma":0.002594396,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001221412,"about_ca_topic_score_gemma":0.002126483,"domain_scores_codex":[0.9993932,0.0002774591,0.00002840219,0.0001032891,0.0000493226,0.0001483757],"domain_scores_gemma":[0.9986585,0.0001582125,0.0002183935,0.0001574203,0.00007036934,0.0007370927],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.718208,0.1838787,0.004679547,0.0004778333,0.0006933312,0.0002411086,0.0003256145,0.001809352,0.03944957,0.0002190419,0.002792573,0.04722529],"study_design_scores_gemma":[0.3814797,0.6084191,0.005492387,0.00001932494,0.0001666508,0.0001460851,0.00003026225,0.0007518749,0.00235618,0.00009310652,0.001026561,0.00001868807],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9923551,0.0009383513,0.0004690739,0.000399483,0.000155612,0.003575043,0.0008577041,0.000109667,0.001139946],"genre_scores_gemma":[0.985275,0.001073422,0.001659865,0.0008947913,0.0002724754,0.005312271,0.00265348,0.00004013592,0.00281845],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003688153,"threshold_uncertainty_score":0.01310492,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1622952757456171,"score_gpt":0.4887205003942324,"score_spread":0.3264252246486153,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}